Bringing Cure...Building Hope...
Home | Blog | Events
Pharma legitimate consultant and facilitator in Delhi India

PRALUENT (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015. Available In India

PRALUENT is an injectable prescription medicine used: • in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina) requiring hospitalization.. PRALUENT (alirocumab) injection can be imported for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

Generic Name: alirocumab Brand Name: PRALUENT
PRALUENT (alirocumab) injection is used for the treatment of patients with cardiovascular disease to reduce the risk of heart attack, stroke.

Therapeutic indications and Usage PRALUENT is an injectable prescription medicine used:
* in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina) requiring hospitalization. * along with diet, alone or together with other cholesterol-lowering medicines in adults with high blood cholesterol levels called primary hyperlipidemia (including a type of high cholesterol called heterozygous familial hypercholesterolemia), to reduce low-density lipoprotein cholesterol (LDL-C) or bad cholesterol. * along with other LDL-lowering treatments in adults with a type of high cholesterol called homozygous familial hypercholesterolemia who need additional lowering of LDL-C.
It is not known if PRALUENT is safe and effective in children. Medicine Name: PRALUENT
Generic Name: alirocumab
Approval Date: 2015
Treatment of: cardiovascular.
Company Name: Regeneron Pharmaceuticals, Inc.
Source Details: Patient Information

Patient Name Basis Treatment IPN, New Delhi can facilitate patient to import of "PRALUENT (alirocumab) injection" in quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).

Health Professional In India If you have any question, please email IPN Support Team or Call Indian Pharma Network for PRALUENT (alirocumab) injection price list or cost in India. on
Mr. Tarun:- +91 9891 296 838
Mr. Neeraj:- +91 9811 747 774

Indian Pharma Network, New Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals.
Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Mumbai | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur | Punjab | Chandigarh
Our Overseas Network Uk | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

PRALUENT (alirocumab) injectioninjection price in India UK
Note:-

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

PRALUENT is not a statin. Statins help lower the production of bad cholesterol. PRALUENT works by blocking a protein (called PCSK9) that contributes to high levels of bad cholesterol. Adding PRALUENT helps increase your liver’s ability to clear bad cholesterol from your bloodstream. Though they work differently, PRALUENT and statins can work together to lower your bad cholesterol when added to a healthy diet. PRALUENT may be used with or without other cholesterol-lowering medications. PRALUENT is an injectable medication called a PCSK9 inhibitor. It is taken every 2 weeks or 4 weeks (monthly). Click here for more information about dosing PRALUENT.

Source content : www.accessdata.fda.gov

IPN, New Delhi can facilitate patient to import of "PRALUENT (alirocumab) injection" in quantities for personal use. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Visakhapatnam, Surat, Jaipur, Coimbatore, Kanpur, Nagpur, Raipur, Kochi, Kozhikode, Nashik, Salem, Thiruvananthapuram, Madurai, Jodhpur, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. with over 20 years of domain experience.

For procurement cost of PRALUENT (alirocumab) injection in India, Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the PRALUENT (alirocumab) injection medicine cost price in India.

The order for PRALUENT (alirocumab) injection will be confirmed only after
1. submitting Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).
2. Permission from obtained from the office of the Drugs Controller General (India).
3. Availability of PRALUENT (alirocumab) injection from authorised distributor.

Alirocumab injection is used along with diet, alone or in combination with other cholesterol-lowering medications (HMG-CoA reductase inhibitors [statins] or ezetimibe [Zetia, in Liptruzet, in Vytorin]), in adults who have familial heterozygous hypercholesterolemia (an inherited condition in which cholesterol cannot be removed from the body normally) to decrease the amount of low-density lipoprotein (LDL) cholesterol ('bad cholesterol') in the blood. It is also used in adults with cardiovascular disease to lower the risk of stroke, heart attack, or serious or life-threatening chest pain. Alirocumab injection is also used with other medications to treat homozygous familial hypercholesterolemia (HoFH; an inherited condition in which cholesterol cannot be removed from the body normally) in adults to decrease LDL cholesterol. Alirocumab injection is in a class of medications called proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor monoclonal antibodies. It works by blocking the production of LDL cholesterol in the body therefore decreasing the amount of cholesterol that may build up on the walls of the arteries.

PRALUENT (alirocumab) injection, for subcutaneous use.
Initial U.S. approval: 2015

• Injection: 75 mg/mL or 150 mg/mL solution in a single-dose pre-filled pen
• Injection: 75 mg/mL or 150 mg/mL solution in a single-dose pre-filled syringe

Alirocumab, sold under the brand name Praluent, is a medication used as a second-line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors, and it was the first such agent to receive FDA approval. The FDA approval was contingent on the completion of further clinical trials to better determine efficacy and safety. It was approved for medical use in the United States and in the European Union in 2015. For highlights of prescribing information PRALUENT (alirocumab) injection.

For PRALUENT Supplied/Storage and Handling please go through For highlights of prescribing information.

For PRALUENT Description, please go through For highlights of prescribing information.

For PRALUENT ingredients, please go through For highlights of prescribing information.

Instructions for Preparation and Administration, please go through For highlights of prescribing information.

Yes, In November 2015, the U.S. Food and Drug Administration (FDA) approved alirocumab.

For PRALUENT (alirocumab) injectionIndications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

FDA approves add-on therapy for patients with genetic form of severely high cholesterol For More Details

Praluent (Alirocumab) - Subcutaneous For More Details

Step 1. Send a request for your medicine online:- Applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).

Step 2. Verification of documents:- We verify your a prescription and necessary documents to import drugs in quantities for personal use.

Step 3. Permission to Import:- After getting approval of Drugs Controller General (India), we start the process to import of drugs as mentioned in prescription for personal use.

Step 4. We source your medicine:- Our expert sourcing team work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 5. Delivery of medicine:- After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Doctor’s Prescription –
We would require prescription from Registered Medical Practitioner (RMP) stating product name, dosage, duration of treatment and diagnosis.

Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.

Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process.

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. Indian Pharma Network, New Delhi can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find out -
PRALUENT (alirocumab) injection price in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
PRALUENT (alirocumab) injection price in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
PRALUENT (alirocumab) injection price in North America – Mexico.
PRALUENT (alirocumab) injection price in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
PRALUENT (alirocumab) injection price in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
PRALUENT (alirocumab) injection price in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
PRALUENT (alirocumab) injection price in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
PRALUENT (alirocumab) injection price in Australia and New Zealand.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

Get Access To PRALUENT (alirocumab) injection In India

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in Hodgkin cardiovascular treatment. Brand Name "PRALUENT (alirocumab) injection" or Generic Name "alirocumab for injection" can be imported for personal use under "patient name basis" treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.